A detailed history of Peapack Gladstone Financial Corp transactions in Abbott Laboratories stock. As of the latest transaction made, Peapack Gladstone Financial Corp holds 127,084 shares of ABT stock, worth $16.6 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares
127,084
Previous 129,810 2.1%
Holding current value
$16.6 Million
Previous $14.8 Million 2.88%
% of portfolio
0.21%
Previous 0.21%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

SELL
$111.93 - $119.39 $305,121 - $325,457
-2,726 Reduced 2.1%
127,084 $14.4 Million
Q3 2024

Nov 26, 2024

SELL
$100.07 - $118.13 $145,001 - $171,170
-1,449 Reduced 1.1%
129,810 $14.8 Million
Q2 2024

Aug 13, 2024

SELL
$100.73 - $112.44 $313,572 - $350,025
-3,113 Reduced 2.32%
131,259 $13.6 Million
Q1 2024

May 10, 2024

SELL
$109.52 - $120.96 $71,626 - $79,107
-654 Reduced 0.48%
134,372 $15.3 Million
Q4 2023

Feb 13, 2024

BUY
$90.19 - $110.4 $230,615 - $282,292
2,557 Added 1.93%
135,026 $14.9 Million
Q3 2023

Nov 14, 2023

SELL
$95.53 - $114.62 $52,828 - $63,384
-553 Reduced 0.42%
132,469 $12.8 Million
Q2 2023

Aug 14, 2023

BUY
$100.78 - $112.29 $856,730 - $954,577
8,501 Added 6.83%
133,022 $14.5 Million
Q1 2023

May 15, 2023

SELL
$96.86 - $114.01 $250,189 - $294,487
-2,583 Reduced 2.03%
124,521 $12.7 Million
Q4 2022

Feb 14, 2023

SELL
$95.06 - $111.52 $56,750 - $66,577
-597 Reduced 0.47%
127,104 $14 Million
Q3 2022

Nov 10, 2022

BUY
$96.76 - $112.03 $1.2 Million - $1.39 Million
12,398 Added 10.75%
127,701 $12.4 Million
Q2 2022

Aug 12, 2022

SELL
$102.07 - $123.37 $145,653 - $176,048
-1,427 Reduced 1.22%
115,303 $12.5 Million
Q1 2022

May 16, 2022

SELL
$114.02 - $139.04 $110,143 - $134,312
-966 Reduced 0.82%
116,730 $13.8 Million
Q4 2021

Feb 15, 2022

SELL
$115.53 - $141.46 $63,310 - $77,520
-548 Reduced 0.46%
117,696 $16.6 Million
Q3 2021

Nov 15, 2021

BUY
$116.66 - $129.06 $1.15 Million - $1.27 Million
9,843 Added 9.08%
118,244 $14 Million
Q2 2021

Aug 16, 2021

BUY
$105.79 - $124.53 $32,794 - $38,604
310 Added 0.29%
108,401 $12.6 Million
Q1 2021

May 14, 2021

BUY
$108.84 - $128.23 $492,392 - $580,112
4,524 Added 4.37%
108,091 $13 Million
Q4 2020

Feb 16, 2021

BUY
$105.0 - $114.42 $32,130 - $35,012
306 Added 0.3%
103,567 $11.3 Million
Q3 2020

Nov 16, 2020

SELL
$91.64 - $111.29 $74,228 - $90,144
-810 Reduced 0.78%
103,261 $11.2 Million
Q2 2020

Aug 14, 2020

SELL
$76.57 - $98.0 $39,739 - $50,862
-519 Reduced 0.5%
104,071 $9.52 Million
Q1 2020

May 15, 2020

BUY
$62.82 - $91.86 $65,835 - $96,269
1,048 Added 1.01%
104,590 $8.25 Million
Q4 2019

Feb 14, 2020

BUY
$78.51 - $87.4 $42,630 - $47,458
543 Added 0.53%
103,542 $8.99 Million
Q3 2019

Nov 13, 2019

SELL
$81.84 - $88.74 $581,800 - $630,852
-7,109 Reduced 6.46%
102,999 $8.62 Million
Q2 2019

Aug 15, 2019

SELL
$72.88 - $85.0 $8,381 - $9,775
-115 Reduced 0.1%
110,108 $9.26 Million
Q1 2019

May 15, 2019

BUY
$66.22 - $80.06 $97,343 - $117,688
1,470 Added 1.35%
110,223 $8.81 Million
Q4 2018

Feb 14, 2019

BUY
$65.56 - $74.27 $2,425 - $2,747
37 Added 0.03%
108,753 $7.87 Million
Q3 2018

Nov 14, 2018

BUY
$60.81 - $73.36 $289,212 - $348,900
4,756 Added 4.57%
108,716 $7.98 Million
Q2 2018

Aug 09, 2018

BUY
$57.57 - $63.54 $74,610 - $82,347
1,296 Added 1.26%
103,960 $6.34 Million
Q1 2018

May 10, 2018

BUY
$56.27 - $63.62 $111,133 - $125,649
1,975 Added 1.96%
102,664 $0
Q4 2017

Feb 14, 2018

BUY
$53.68 - $57.47 $107,252 - $114,825
1,998 Added 2.02%
100,689 $0
Q3 2017

Nov 14, 2017

SELL
$48.06 - $53.64 $496,748 - $554,423
-10,336 Reduced 9.48%
98,691 $0
Q2 2017

Aug 14, 2017

BUY
N/A
109,027
109,027 $0

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $229B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Peapack Gladstone Financial Corp Portfolio

Follow Peapack Gladstone Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peapack Gladstone Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Peapack Gladstone Financial Corp with notifications on news.